BCL2 overexpression is a hallmark of CLL pathogenesis that depends on different mechanisms, including miR-15 and miR-16 loss, hypomethylation of the BCL2 gene, and upregulation of STAT3 [120,121,122,123]. Here, BCL2 is linked to B-cell chronic lymphocytic leukemia.